O-glycosylation of ENO1 at serine 63 by GALNT14 promotes triple-negative breast cancer progression by enhancing ENO1 protein stability
- DOI
- 10.1016/j.bbadis.2026.168527
- Published
- 2026-11
- Container
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbadis.2026.168527,
title = {O-glycosylation of ENO1 at serine 63 by GALNT14 promotes triple-negative breast cancer progression by enhancing ENO1 protein stability},
author = {Yuqiu Wan and Jing Lan and Yuhui Zhou and Yang Shi},
year = {2026},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
doi = {10.1016/j.bbadis.2026.168527},
url = {https://doi.org/10.1016/j.bbadis.2026.168527}
}RIS
TY - JOUR TI - O-glycosylation of ENO1 at serine 63 by GALNT14 promotes triple-negative breast cancer progression by enhancing ENO1 protein stability AU - Yuqiu Wan AU - Jing Lan AU - Yuhui Zhou AU - Yang Shi PY - 2026 JO - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease DO - 10.1016/j.bbadis.2026.168527 UR - https://doi.org/10.1016/j.bbadis.2026.168527 ER -
APA
Wan, Y., Lan, J., Zhou, Y., & Shi, Y. (2026). O-glycosylation of ENO1 at serine 63 by GALNT14 promotes triple-negative breast cancer progression by enhancing ENO1 protein stability. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2026.168527
Source records
- crossref · retrieved 2026-11-09T07:03:14.898Z